Aiforia Technologies Plc

Aiforia Technologies Plc
Aiforia provides AI-powered image analysis solutions for pathology, assisting pathologists and scientists in preclinical and clinical labs.
About
Aiforia is a Helsinki-based life-science company that provides deep learning AI solutions for pathology. They offer software solutions that elevate diagnostic capabilities in image analysis, enabling medical discoveries. Their platform equips pathologists and scientists in preclinical and clinical labs with powerful deep-learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. Teams look it up for HealthTech, Biotechnology, Artificial Intelligence.
Tempus AI acquired Paige, a digital pathology company that develops AI-assisted diagnostic and biomarker applications, directly competing with Aiforia's AI-powered image analysis solutions for pathology.
Roche is acquiring PathAI, a digital pathology firm specializing in AI-powered technology for pathology laboratories and the biopharma industry, which directly competes with Aiforia's offerings in AI-driven pathology image analysis.
Danaher's operating company, Leica Biosystems, has a strategic investment and partnership with Indica Labs, a leader in AI-powered digital pathology software, creating a competing platform for AI-enabled cancer diagnostics.
Philips offers end-to-end digital pathology platforms that leverage AI and cloud-based solutions for remote collaboration and clinical standardization, directly competing with Aiforia's AI-powered image analysis for pathology.
Labcorp is actively expanding its digital pathology capabilities and has collaborated with Roche to implement digital slide scanners and integrate AI-driven insights into their pathology workflow, aligning with Aiforia's offerings.
Memorial Sloan Kettering Cancer Center has a history of collaborating with AI pathology companies and possesses a massive dataset of digitized pathology slides, indicating a need for advanced AI image analysis solutions like Aiforia's.
University Medical Center Utrecht has engaged in health economics research to assess AI in clinical environments, demonstrating an interest in integrating AI pathology solutions for improved diagnostics.
Sonora Quest Laboratories has partnered to implement fully digital pathology workflows, suggesting a readiness to adopt AI-powered image analysis to enhance diagnostic accuracy and efficiency.
Thermo Fisher Scientific is actively deepening its digital and data capabilities and advancing its use of AI to speed clinical research and drug development, which aligns with Aiforia's solutions for preclinical and clinical labs.
Buyer fit inferred by StartupHub from what Aiforia Technologies Plc sells and public signals about each company. Only rows badged "already a customer" are confirmed relationships.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.